PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
33.96%
Revenue growth above 1.5x FSLR's 18.16%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-13.81%
Negative gross profit growth while FSLR is at 18.16%. Joel Greenblatt would examine cost competitiveness or demand decline.
3.34%
Positive EBIT growth while FSLR is negative. John Neff might see a substantial edge in operational management.
3.34%
Positive operating income growth while FSLR is negative. John Neff might view this as a competitive edge in operations.
60.74%
Positive net income growth while FSLR is negative. John Neff might see a big relative performance advantage.
34.50%
Positive EPS growth while FSLR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
34.50%
Positive diluted EPS growth while FSLR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-16.12%
Share reduction while FSLR is at 0.79%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-16.12%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-100.51%
Negative OCF growth while FSLR is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-188.03%
Negative FCF growth while FSLR is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
1468.44%
10Y revenue/share CAGR above 1.5x FSLR's 255.34%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1468.44%
5Y revenue/share CAGR above 1.5x FSLR's 255.34%. David Dodd would look for consistent product or market expansions fueling outperformance.
1468.44%
3Y revenue/share CAGR above 1.5x FSLR's 255.34%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
84.42%
OCF/share CAGR of 84.42% while FSLR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
84.42%
OCF/share CAGR of 84.42% while FSLR is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
84.42%
3Y OCF/share CAGR of 84.42% while FSLR is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
80.68%
Positive 10Y CAGR while FSLR is negative. John Neff might see a substantial advantage in bottom-line trajectory.
80.68%
Positive 5Y CAGR while FSLR is negative. John Neff might view this as a strong mid-term relative advantage.
80.68%
Positive short-term CAGR while FSLR is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
42.45%
AR growth of 42.45% while FSLR is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
26.21%
Inventory growth of 26.21% while FSLR is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
92.75%
Asset growth of 92.75% while FSLR is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
250.95%
BV/share growth of 250.95% while FSLR is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
No Data
No Data available this quarter, please select a different quarter.
-59.76%
Our R&D shrinks while FSLR invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-183.30%
We cut SG&A while FSLR invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.